中国药师-专业站 - 近期刊登

川芎嗪对大鼠缺血再灌注肾脏功能的影响-07.11

阅读: 时间: 2008-2-18 15:57:00

马传荣  汪燕  贺国芳  方建国  杜光  姜汉英  (华中科技大学同济医学院附属同济医院药学部  武汉 430030)

摘  要  目的:通过研究不同浓度的川芎嗪(tertramethylpyrazine, TMP)在大鼠肾脏缺血再灌注损伤过程中的作用,探讨川芎嗪对肾脏组织发挥保护作用的最佳浓度。方法:建立大鼠肾脏缺血再灌注模型,分别检测假手术组、模型组、川芎嗪用药组(川芎嗪15,30,45,60,90 mg•kg-1)血肌酐(Cr)和尿素氮(BUN)水平,观察肾组织形态并测定其中的诱导型一氧化氮合酶(induced nitric oxide synthase, iNOS)活性。结果:15mg•kg-1和30 mg•kg-1组川芎嗪显著降低肾组织内iNOS的活性,降低血浆Cr和BUN水平,减轻肾小管上皮细胞坏死程度,以15 mg•kg-1最为显著;45 mg•kg-1组血Cr和BUN水平及肾小管坏死程度低于模型组,但高于假手术组,且均有显著性差异;60 mg•kg-1组和90 mg•kg-1组血Cr和BUN反而上升,小管上皮细胞坏死比模型组明显加重,肾组织内iNOS较模型组变化不明显。结论:合适剂量(15~45 mg•kg-1)的川芎嗪可以通过降低iNOS活性,保护缺血再灌注肾功能,减轻肾组织病理损害,以15 mg•kg-1最为显著,随剂量增加保护作用减弱。而较高浓度(45~90 mg•kg-1)川芎嗪失去对缺血再灌注肾脏的保护作用。 

关键词  川芎嗪;缺血再灌注损伤;诱导型一氧化氮合酶 

中图分类号:R285.5

文献标识码:A

文章编号:1008-049X(2007)11-1051-03

Effects of Tertramethylpyrazine(TMP)  in Kidney Ischemia Reperfusion in Rats

Ma Chuanrong,Wang Yan,He Guofang, Fang Jianguo, Du Guang, Jiang Hanying( Department of Pharmacology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. Wuhan 430030, China)

ABSTRACT  Objective:To explore the effects and the optimal protective dose of tertramethylpyrazine (TMP) in kidney ischemia reperfusion in rats based on different concentration.Method:The rats were randomly divided into three groups: sham operation group, ischemia-reperfusion group and treatment group(TMP 15,30,45,60,90 mg•kg-1  by intravenous injection respectively).The renal ischemia reperfusion models were established. Serum levels of blood creatinine (Cr) and urea nitrogen (BUN) were measured. The activities of iNOS in kidney and the pathological variety were detected in all rats.Result:Compared to ischemia-reperfusion group,TMP 15 mg•kg-1 and 30 mg•kg-1presented with significantly lower levels of Cr and BUN (P<0.01,P<0.01)than those in the model group. Moreover the activity of iNOS in kidney was decreased markedly (P<0.01,P<0.01).The renal tubular epithelial cell showed less edema, denaturation or necrosis and apoptosis were alleviated markedly, especially the TMP 15 mg•kg-1 group. The renal function and the tubular epithelial cell death damage in TMP 45 mg•kg-1group were decreased, but were aggravated than sham operation group. TMP 60 mg•kg-1 and 90 mg•kg-1increased the levels of Cr and BUN in plasma and the histological lesions and apoptosis of renal tissue was significantly aggravated compared with sham operation group, however the change of activities of iNOS in kidney were not obvious.Conclusion: TMP of appropriate dose(15-45 mg•kg-1) were proved to have protective effect on renal function and relieve the pathological lesion of renal tissue  through decreasing the activity of iNOS  in kidney after ischemia-reperfusion injury,especially the TMP 15 mg•kg-1; Following the dose of TMP increased,the protective effect is lessened .However high concentration of TMP(45-90 mg•kg-1) lost its protective effect on ischemia reperfusion kidney.

KEY WORDS  Tertramethylpyrazine;Renal ischemia reperfusion injury; Induced nitric oxide synthase

参  考  文  献

1  王艳萍,李文兰,范玉奇.川芎嗪药理作用的研究进展[J].药品评价,2006,3(2):144-146
2  沈寅初,李维才,王名贵.丹参对热缺血肾保护作用的实验研究[J].中华实验外科杂志,1988,26(12):759-761
3 Pallone TL, Mattson DL. Role of nitric oxide in regulation of the renal medulla in normal and hypertensive kidneys [J]. Curr Opin Nephrol Hypertens,2002,11(1):93-98
4  Zollner S, Aberle S, Harvey SE,et al. Changes of endothelial nitric oxide synthase level and activity during endothelial cell proliferation [J].Endothelium,2000,7(3):169-184
5  Sasaki T,Hamada j,Shibata M,et al.Inhibition of nitric oxide production during global ischemia ameliorates ischemic damage of pyramidal neurons in the hippocampus [J].Keio J Med,2001,50(3):182-187
6  秦升,韩克俊.川芎嗪抗缺血再灌注损伤研究进展[J].中国中医药信息杂志, 2004,11(3):268-269
7  梁国标,沈寅初, 陈代雄,等.大鼠缺血再灌注肾组织一氧化氮合成酶mRNA表达的研究[J].贵州医药,2001, 25(10):867-870
8  徐浩,史大卓,管昌益.川芎嗪的临床应用和药理作用[J].中西医结合杂志,2003,23(5):376-378

资料来自:中国药师-专业站
参与评论(条评论)
发表评论请遵守国家法律
笔名:
邮箱:
查看评论

搜索
请输入关键词:
网上调查
相关资源
  • 磷酸川芎嗪胶囊的人体生物等效性研究-07.6 [2007-6-15]
  • 乌司他汀对大鼠肝脏缺血再灌注损伤的保护作用-07.6 [2007-6-15]
  • 川芎嗪及其联合用药的临床研究概况-07.5 [2007-5-11]
  • 川芎嗪的治疗作用研究-07.3 [2007-3-2]
  • 川芎嗪可改善AMI溶栓后血管内皮功能 [2005-8-31]
  • 川芎嗪可改善AMI溶栓后血管内皮功能 [2005-8-24]
  • 环孢素A联合静脉注射用丙种球蛋白和川芎嗪治疗小儿重型再生障碍性贫血 [2005-7-4]
  • 葡萄籽原花青素抗大鼠脑缺血再灌注损伤的研究 [2005-7-2]